Clinical Testing of Limb-Girdle Muscular Dystrophy (LGMD2A and LGMD2B)

We test for point mutations in Calpain-3, CAPN3 (autosomal recessive limb-girdle muscular dystrophy-2A, see GeneReview) and Dysferlin, DYSF (autosomal recessive limb-girdle muscular dystrophy-2B, see GeneReview). You will be responsible for the costs of having the blood drawn, and for shipping it by overnight courier to the University of Utah Genome Center. In order for your sample to be processed, you need to send along the information/billing and DNA testing consent form.

Methodology

Fluorescence-based, bidirectional Sanger dideoxy sequencing of PCR amplicons spanning all coding regions and intron/exon boundaries for:

  • CAPN3 gene
  • DYSF gene

Capillary electrophoresis is performed using an ABI 3730xl DNA Analyzer.

Costs

  • $1,500 Direct sequencing analysis of the CAPN3 and DYSF genes
  • $1,250 Direct sequencing analysis of the DYSF gene
  • $1,150 Direct sequencing analysis of the CAPN3 gene
  • $250 Sequencing of a single exon (For family members of patients with previously detected mutations)

Results

Your physician will receive results by e-mail and mail in approximately six (6) to eight (8) weeks.